Selected Publications

  1. Kamel ES, Rahman Y, Mahoney JC, Anderson EJ, Nejadnik R. Development of a Piezoelectric Immunosensor to Rapidly Measure Prohibitin-1 as a Prognostic Biomarker for Sepsis and Other Serious Infectious Diseases. ACS applied electronic materials, 2025.
  2. Hejmady S, Taherian E, Nejadnik R. A Tale of Two Stressors in Biologic Drug Product Development: Shaking Mode and Primary Packaging. Pharmaceutical research, 2025.
  3. Parnian P, Arnold MA, Nejadnik R. Characterizing protein-protein interactions in mAb formulations: A comparative study of kD, B22, and DLVO framework. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2025.
  4. Sina Sarsarshahi, Sanghati Bhattacharya, Zeb R. Zacharias, Eman S. Kamel, Jon CD Houtman, and Reza Nejadnik. Highly variable aggregation and glycosylation profiles and their roles in immunogenicity to protein-based therapeutics. Journal of Pharmaceutical Sciences, 2025.
  5. Aziz Ahmad, Hesham Refaat, Sanghati Bhattacharya, Vadim J. Gurvich, Anurag S. Rathore, Reza Nejadnik, and Raj Suryanarayanan. Effect of formulation composition on trastuzumab stability. International Journal of Pharmaceutics, 2025.
  6. Hesham Refaat, Aziz Ahmad, Eman Kamel, Vadim J. Gurvich, Anurag S. Rathore, Raj Suryanarayanan, and Reza Nejadnik. Challenges with effective removal of surfactants from monoclonal antibody formulations. International journal of pharmaceutics, 2025.
  7. Yusra Rahman, Siddhanth Hejmady, Reza Nejadnik. Prediction of Self-Association and Solution Behavior of Monoclonal Antibodies Using the QCM-D Metric of Loosely Interacting Layer. Molecular Pharmaceutics, 2024.
  8. Deepika Sarin, Kunal Krishna, M. Reza Nejadnik, Raj Suryanarayanan, and Anurag S. Rathore. Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability. Molecular Pharmaceutics, 2024.
  9. Fast J, Christian T, Crul M, Jiskoot W , Nejadnik MR, Medina A, Radwick, A, Sreedhara, A, & Tole, H. Use of Closed System Transfer Devices (CSTDs) with Protein-Based Therapeutic Drugs-A Non-Solution for a Non-Problem? Journal of Pharmaceutical Sciences, 2024.
  10. Sreedhara A, Buecheler J, Brosig S, Chou D, Christian T, Das T, de Jong I, Fast J, Jagannathan B, Medina Morales A, Moussa EM, Nejadnik MR, Prajapati I, Radwick A, Rahman Y & Singh S. End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics, The AAPS Journal, 2023.
  11. Nejadnik MR, Randolph TW, Volkin DB, Schöneich C, Carpenter JF, Crommelin DJA, Jiskoot W. Post-production handling and administration of protein pharmaceuticals and potential instability issues. Journal of Pharmaceutical Sciences, 2018.
  12. Jiskoot W, Nejadnik MR, Sediq AS. Potential issues with the handling of biologicals in a hospital. Journal of Pharmaceutical Sciences, 2017.
  13. Tian X, Nejadnik MR, Baunsgaard D, Henriksen A, Rischel C, Jiskoot W. A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles. Journal of Pharmaceutical Sciences, 2016.
  14. Sediq AS, Van Duijvenvoorde R, Jiskoot W, Nejadnik MR. No touching! Abrasion of adsorbed protein is the root cause of subvisible particle formation during stirring. Journal of Pharmaceutical Sciences, 2016.
  15. Nejadnik MR, Jiskoot W. Measurement of the average mass of proteins adsorbed to a nanoparticle by using a suspended microchannel resonator. Journal of Pharmaceutical Sciences, 2015.

Full List of Publications

Click Here